MDPile
SpecialtyNews
RSS icon
MDPile

  • New Hope for Acute Kidney Injury: First Patient Dosed in Auxora Phase 2 Trial

    New Hope for Acute Kidney Injury: First Patient Dosed in Auxora Phase 2 Trial

    7/9/2024

  • Exciting Development in Chronic Kidney Disease Treatment: SC0062 Shows Promising Results

    Exciting Development in Chronic Kidney Disease Treatment: SC0062 Shows Promising Results

    7/8/2024

  • Breakthrough in Managing Kidney Transplant Rejections with VitaGraft

    Breakthrough in Managing Kidney Transplant Rejections with VitaGraft

    5/30/2024

  • Revolutionizing Kidney Care: Semaglutide’s Promising Role

    Revolutionizing Kidney Care: Semaglutide’s Promising Role

    5/29/2024

  • Antidepressants Ineffective for Reducing Health Risks in CKD Patients

    Antidepressants Ineffective for Reducing Health Risks in CKD Patients

    5/29/2024

  • Revolutionizing Kidney Care: A New Partnership in Southwestern Kentucky

    Revolutionizing Kidney Care: A New Partnership in Southwestern Kentucky

    5/29/2024

  • New Hope for ADPKD Patients: Phase II Clinical Trials for Tamibarotene Underway

    New Hope for ADPKD Patients: Phase II Clinical Trials for Tamibarotene Underway

    5/28/2024

  • New Insights into IgA Nephropathy Treatment: Calliditas Therapeutics Unveils Latest Data

    New Insights into IgA Nephropathy Treatment: Calliditas Therapeutics Unveils Latest Data

    5/28/2024

  • New Insights on IgA Nephropathy Treatments: How Do Sparsentan and Irbesartan Compare?

    New Insights on IgA Nephropathy Treatments: How Do Sparsentan and Irbesartan Compare?

    5/27/2024

  • Link Between Anemia and Kidney Disease Progression: What You Need to Know

    Link Between Anemia and Kidney Disease Progression: What You Need to Know

    5/27/2024

  • New Hope for Kidney Transplant Patients: Pegcetacoplan Shows Promise Against Recurrent C3G and IC-MPGN

    New Hope for Kidney Transplant Patients: Pegcetacoplan Shows Promise Against Recurrent C3G and IC-MPGN

    5/27/2024

  • New Hope for Dialysis Patients: Clazakizumab and Cardiovascular Risk Reduction

    New Hope for Dialysis Patients: Clazakizumab and Cardiovascular Risk Reduction

    5/27/2024

  • Semaglutide: A Lifeline for Kidney Health in Obesity and Heart Disease

    Semaglutide: A Lifeline for Kidney Health in Obesity and Heart Disease

    5/27/2024

  • Promising New Treatment for C3 Glomerulopathy Shows Positive Results

    Promising New Treatment for C3 Glomerulopathy Shows Positive Results

    5/26/2024

  • New Hope for Kidney Transplant Patients with Pegcetacoplan

    New Hope for Kidney Transplant Patients with Pegcetacoplan

    5/26/2024

  • New Hope for Kidney Transplant Patients: Promising Results for Felzartamab

    New Hope for Kidney Transplant Patients: Promising Results for Felzartamab

    5/25/2024

  • Breakthrough in Kidney Disease: Atacicept Shows Promising Results in IgA Nephropathy Study

    Breakthrough in Kidney Disease: Atacicept Shows Promising Results in IgA Nephropathy Study

    5/25/2024

  • Breakthrough in Gene Therapy Offers New Hope for Kidney Disease

    Breakthrough in Gene Therapy Offers New Hope for Kidney Disease

    5/24/2024

  • How Medical Nutrition Therapy Can Transform Care for Chronic Kidney Disease Patients

    How Medical Nutrition Therapy Can Transform Care for Chronic Kidney Disease Patients

    5/21/2024

  • Are We Overdosing Anemia Patients? A Study on Mircera Dosing Practices

    Are We Overdosing Anemia Patients? A Study on Mircera Dosing Practices

    5/20/2024

  • New Hope for Anemia Patients: Investigational Drug Targets Iron Regulation

    New Hope for Anemia Patients: Investigational Drug Targets Iron Regulation

    5/20/2024

  • New Test and Remote Monitoring Improve Hypertension in Diabetic Kidney Disease

    New Test and Remote Monitoring Improve Hypertension in Diabetic Kidney Disease

    5/19/2024

  • Finerenone Shows Promise in Slowing Kidney Disease After Heart Failure

    Finerenone Shows Promise in Slowing Kidney Disease After Heart Failure

    5/15/2024

  • Finerenone Shows Hope in Slowing Kidney Disease After Heart Failure

    Finerenone Shows Hope in Slowing Kidney Disease After Heart Failure

    5/15/2024

  • Alarming Rates of CKM Syndrome Among U.S. Adults: A Call for Improved Healthcare Strategies

    Alarming Rates of CKM Syndrome Among U.S. Adults: A Call for Improved Healthcare Strategies

    5/13/2024

...
0
Terms & Conditions
Privacy Policy
MDPile